News

The results of the AXADIA-AFNET8 trial and another EAST-AFNET4 subanalysis will be presented at this year’s AHA congress (Chicago, US) :

Featured Science Session (FS.03): Featured Science in Heart Rhythm Medicine
Apixaban or vitamin K antagonists for stroke prevention in patients with atrial fibrillation on hemodialysis: Results of the randomized AXADIA-AFNET 8 trial
Monday, 7th of November 2022 | 0:20 – 0:30 (CET) / Sunday, 6th of November 2022 | 5:20pm – 5:30pm (CST)
Speaker: Dr. Paulus Kirchhof
More information

Session 0880 – Plenary 01: Opening, Presentation of Award and Late Breaking Trials (ID 294) Early rhythm-control therapy for atrial fibrillation in patients with history of stroke in the EAST-AFNET4 trial
Wednesday, 26th of October 2022 | / 12:10 – 12:20 pm (CEST)/ 18:10 – 18:20 pm (SGT), room “Hall 406”
Speaker: Märit Jensen

The study “CABA-HFPEF-DZHK27” (CAtheter-Based Ablation of atrial fibrillation vs. conventional treatment in patients with Heart Failure with Preserved Ejection Fraction) is aiming for a better therapy for patients with heart failure and atrial fibrillation. Charité (Berlin, Germany) has the overall responsibility for the study. This trial is supported by German Centre for Cardiovascular Research (DZHK). Further information can be found in the press release (german only). 

The 8th AFNET/EHRA Consensus Conference Paper 2021 “Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation” has been published:

The current issue of “theme booklet of neurology” reports on Atrial Fibrillation NETwork (AFNET), get your access here (german only).

The newest subanalysis of the EAST-AFNET 4 study will be presented at this year’s ESC congress 2022 in Barcelona:

The design paper was successfully published in “Frontiers in cardiovascular medicine”. Get access to the paper here. 

The latest results of the EAST – AFNET 4  study will be presented at this year’s ESC Congress 2021 (streamed live):

Late Breaking Science in Arrhythmias
Benefit of early rhythm control therapy in patients with asymptomatic AF -insights from EAST-AFNET 4
Friday, 27th of August 2021 | 10.30am – 11:15am (CEST)
Presented by Prof. Dr. Stephan Willems

The latest results of the EAST – AFNET 4  study will be presented at this year’s HRS in Boston.

Early Rhythm Control Therapy In Patients With Atrial Fibrillation And Heart Failure (PD Dr. Andreas Rillig)
Live-Stream from the Heart Rhythm Society (HRS 2021), Boston, USA.
Friday, 30 July 2021
10:45am – 10:53am Eastern time / 4:45pm – 4:53pm CEST
More information

Early Rhythm Control for the Treatment of Atrial Fibrillation (Prof. Dr. Paulus Kirchhof)
Live-Stream from the Heart Rhythm Society (HRS 2021), Boston, USA.
Friday, 30 July 2021
1:30pm – 2:30pm Eastern time / 7:30pm – 8:30pm CEST
More information